Breakthrough combo therapy lowers death risk in recurrent prostate cancer
View as a Web Page
News Medical
 
  Prostate Cancer Prostate Cancer logo  
  The latest prostate cancer news from News Medical  
 Study confirms PSA screening improves survival and safetyStudy confirms PSA screening improves survival and safety
 
After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower prostate cancer mortality with PSA testing and an improved harm–benefit ratio over time. Risk-based screening could sustain mortality gains while reducing overdiagnosis and unnecessary treatment.
 
 
 Breakthrough combo therapy lowers death risk in recurrent prostate cancerBreakthrough combo therapy lowers death risk in recurrent prostate cancer
 
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.
 
   New imaging technique boosts survival in prostate cancer patientsNew imaging technique boosts survival in prostate cancer patients
 
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St.
 
   Study provides a new approach for the treatment of prostate tumorsStudy provides a new approach for the treatment of prostate tumors
 
An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.
 
   Blocking two enzymes weakens prostate tumors and boosts drug effectivenessBlocking two enzymes weakens prostate tumors and boosts drug effectiveness
 
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men.
 
 Do GLP-1 drugs cause cancer? New review says no, may even protect
 
Do GLP-1 drugs cause cancer? New review says no, may even protectA comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and increased cancer risk, countering early safety concerns. Instead, evidence suggests possible protective effects for certain cancers, supported by metabolic and immune-modulating mechanisms.
 
 
 USC-led study advances understanding of prostate cancer genetics in Black men
 
USC-led study advances understanding of prostate cancer genetics in Black menNew prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ancestry.
 
 
 Discovery offers a breakthrough approach to combat prostate tumor growth
 
Discovery offers a breakthrough approach to combat prostate tumor growthProstate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes.
 
 
 Over one-third of men would rather endure stressful situations than discuss prostate health
 
Over one-third of men would rather endure stressful situations than discuss prostate healthA new survey from Orlando Health reveals that over one-third of men (38%) would rather endure stressful situations, such as watching their team lose a big game or being stuck in traffic, than discuss their prostate health.
 
 
 PTGES3 emerges as key regulator of androgen receptor in prostate cancer
 
PTGES3 emerges as key regulator of androgen receptor in prostate cancerA poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate cancer.
 
 
 Study identifies thyroid hormone pathway as key player in prostate cancer development
 
Study identifies thyroid hormone pathway as key player in prostate cancer developmentA hormone produced in the thyroid gland can play a key role in the development of prostate cancer.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025